Showing results (2621-2630 of 2,705) with videos related to
Sort By:
Pageof 271
Nature Genetics|August 17, 2023
Genetic insights into human cortical organization and development through genome-wide analyses of 2,347 neuroimaging phenotypesVarun Warrier, Eva-Maria Stauffer, Qin Qin Huang, et al.Science (New York, N.Y.)|October 19, 2023
Rapid ozone depletion after humidification of the stratosphere by the Hunga Tonga EruptionStephanie Evan, Jerome Brioude, Karen H Rosenlof, et al.The American Journal of Tropical Medicine and Hygiene|December 21, 2017
Impact of Enhanced Health Interventions for United States-Bound Refugees: Evaluating Best Practices in Migration HealthTarissa Mitchell, Deborah Lee, Michelle Weinberg, et al.Journal of Medicinal Chemistry|December 22, 2006
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonistMichael P Dwyer, Younong Yu, Jianping Chao, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2018
Identification of second-generation P2X3 antagonists for treatment of painAnthony T Ginnetti, Daniel V Paone, Shaun R Stauffer, et al.The American Journal of Tropical Medicine and Hygiene|May 7, 2020
Clinical Sequelae Associated with Unresolved Tropical Splenomegaly in a Cohort of Recently Resettled Congolese Refugees in the United States-Multiple States, 2015-2018Laura Divens Zambrano, Emily Jentes, Christina Phares, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|January 13, 2022
Acid-base balance at high altitude in lowlanders and indigenous highlandersMichael M Tymko, Christopher K Willie, Connor A Howe, et al.Bioorganic & Medicinal Chemistry Letters|October 18, 2015
Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulatorsChrysa Malosh, Mark Turlington, Thomas M Bridges, et al.Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.JCI Insight|May 5, 2026
Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastomaJesse A Coker, Steven R Martinez, Sang Hoon Han, et al.Pageof 271